2. UroToday Home
  3. Video Lectures

ASCO 2024 Videos

Antibody Drug Conjugate FOR46: Targeting CD46 in mCRPC in Phase 1b Trial - Nonna Shakhnazaryan
August 5, 2024
Details
The Best of ASCO 2024 in Advanced Bladder Cancer - Shilpa Gupta
July 3, 2024
Details
Small Cell Neuroendocrine Carcinoma of Urinary Tract: Relapse Factors & Treatment - Omar Alhalabi
July 2, 2024
Details
PSMAfore Trial: Lutetium PSMA's Impact on mCRPC Quality of Life - Karim Fizazi
July 2, 2024
Details
PROSTATE-IQ Trial: Reducing ADT Burden in Salvage Radiotherapy - Karen Hoffman
June 27, 2024
Details
ENLIGHTED Trial: New Promising Approach for Low-Grade Upper Tract Urothelial Carcinoma - Vitaly Margulis
June 27, 2024
Details
Understanding KEYNOTE-564: Pembrolizumab’s Role and Post-Adjuvant Therapy for RCC Patients - Karl Semaan & Talal El Zarif
June 26, 2024
Details
MAST Trial Finds Metformin Ineffective in Preventing Prostate Cancer Progression - Neil Fleshner
June 26, 2024
Details
VA's Million Veterans Program Reveals Crucial Genetic Data for Prostate Cancer Treatment - Bruce Montgomery
June 25, 2024
Details
Mentorship and Opportunity: Keys to Success in Medicine - Veda Giri
June 25, 2024
Details
SECuRE Trial: Copper-67 SAR-bisPSMA Therapy for Prostate Cancer - Geoffrey Johnson
June 24, 2024
Details
Genomic Alterations and Lutetium PSMA Response in Prostate Cancer - Alexandra Sokolova
June 22, 2024
Details
CYCLONE 2 Trial Results: Abemaciclib in Metastatic Castration-Resistant Prostate Cancer - Matthew Smith
June 22, 2024
Details
Prostate Cancer Diversity Revealed: AR and Neuroendocrine Signatures - Yu-Wei Chen
June 21, 2024
Details
Breaking Barriers in Cancer Treatment and Women's Leadership in Oncology - Ulka Vaishampayan
June 21, 2024
Details
Mental Health and Prostate Cancer in the Veterans Population - Zachary Klaassen
June 20, 2024
Details
BRCA2 and Beyond: Unraveling Genetic Drivers of Prostate Cancer Aggressiveness - Hiba Khan
June 20, 2024
Details
SunRISe-5 Trial: Evaluating TAR-200 for Recurrent High-Risk Non-Muscle Invasive Bladder Cancer - Sima Porten
June 18, 2024
Details
IMPLEMENT Study: Addressing the Underutilization of Treatment Intensification in Metastatic Castration-Sensitive Prostate Cancer - Stacy Loeb
June 18, 2024
Details
Targeting EZH2 in Prostate Cancer: The Role of Mevrometostat in Preventing Neuroendocrine Differentiation - Michael Schweizer
June 18, 2024
Details
Machine Learning Model Predicts Overall Survival in Metastatic Prostate Cancer - Ali Sabbagh
June 17, 2024
Details
Tarlatamab Shows Encouraging Activity in Phase 1 Trial in DLL3-Positive Neuroendocrine Prostate Cancer - Rahul Aggarwal
June 17, 2024
Details
ctDNA Fraction Predicts Response to Lutetium PSMA in TheraP Trial for mCRPC - Edmond Kwan
June 17, 2024
Details
ARAMIS Trial: PSA Responses with Darolutamide Linked to Minimal Radiographic Progression - Alicia Morgans
June 14, 2024
Details
Testicular Cancer Treatment and Cardiovascular Health: Understanding the Long-Term Risks - Khalid Alkhatib
June 14, 2024
Details
Enzalutamide Plus 5-Alpha Reductase Inhibitors for Castrate-Sensitive Prostate Cancer: A Phase 2 Trial - Deepak Kilari
June 13, 2024
Details
Dose-Escalation of Lutetium PSMA: Final Results from a Phase I/II Trial - Scott Tagawa
June 13, 2024
Details
MAST Trial: Investigating Metformin's Role in Prostate Cancer Active Surveillance - Anthony Joshua
June 13, 2024
Details
Exploring Genetic Counseling in Veterans with Advanced Prostate Cancer - Daniel Kwon
June 13, 2024
Details
Advancing Treatment for High-Risk Biochemical Recurrence Prostate Cancer: The ARASTEP Trial - Alexander Chehrazi-Raffle
June 12, 2024
Details
EV-302 Subgroup Analysis: Improved Outcomes for Cisplatin-Ineligible Advanced Urothelial Cancer Patients - Michiel Van der Heijden
June 12, 2024
Details
Cretostimogene Grenadenorepvec: A Novel Oncolytic Immunotherapy for BCG-Unresponsive NMIBC - Roger Li
June 12, 2024
Details
Prognostic Power of Multi-Modal Artificial Intelligence Biomarker in CHAARTED Trial Subset - Mark Markowski
June 12, 2024
Details
OASIS Project Highlights the Survival Benefits of Rapid PSA Decline with Apalutamide in Prostate Cancer - Benjamin Maughan
June 12, 2024
Details
ARV-766: Efficacy and Safety of a Second-Generation AR Degrader in Prostate Cancer - Daniel Petrylak
June 11, 2024
Details
CHAARTED 2 Study Shows PFS Benefit with Cabazitaxel in Metastatic Prostate Cancer in Phase 2 - Christos Kyriakopoulos
June 11, 2024
Details
Integrating Genetic Variants and Clinical Factors for Improved Prostate Cancer Prognostication - Susan Halabi
June 11, 2024
Details
PROMISE Criteria: Enhanced Survival Prediction in Prostate Cancer with PSMA PET - Wolfgang Fendler
June 11, 2024
Details
hK2-Targeted Radioligand Shows Promise in Treating Advanced Prostate Cancer: Phase I Findings - Michael Morris
June 11, 2024
Details
Predicting Response to Bipolar Androgen Therapy: A Blood-Based Biomarker Approach - Samuel Denmeade
June 10, 2024
Details
CORE-001 Study Demonstrates Promising Results for Bladder Cancer with Cretostimogene Grenadenorepvec and Pembrolizumab - Trinity Bivalacqua & Roger Li
June 6, 2024
Details
Behavioral Interventions for Mitigating ADT Side Effects in Prostate Cancer - Brian Gonzalez
May 29, 2024
Details